Patents by Inventor Josef G. Meingassner

Josef G. Meingassner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7419976
    Abstract: Pharmaceutically active diazepanes, e.g. useful for treating disorders or diseases mediated by LFA-1/ICAM-1, LFA-1/ICAM-2, LFA-1/ICAM-3 or LFA-1/JAM-1 interactions.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: September 2, 2008
    Assignee: Novartis AG
    Inventors: Berndt Oberhauser, Josef G Meingassner
  • Patent number: 7259170
    Abstract: A pharmaceutical compound comprising a compound of formula I and a pharmaceutically acceptable 2-amino-1,3-propanediol beside one or more pharmaceutically acceptable excipient(s).
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: August 21, 2007
    Assignee: Novartis AG
    Inventor: Josef G Meingassner
  • Patent number: 6399599
    Abstract: Compounds of formula I wherein n is 1, 2 or 3; R1 is H, C1-4alkyl, aryl, or aryl-C1-4alkyl; Y is C1-4alkylene, —CO—C1-4alkylene, —CO—C2-5alkenylene, —CO—NH—, —CO—C1-3alkylene-NH—, or —CO—O—; R2 is an aromatic or heteroaromatic residue, each being optionally substituted by CF3, halogen, OH, C1-4alkoxy, amino, mono- or di-C1-4alkyl substituted amino, phenyl, benzyl or C1-4alkyl optionally substituted by amino; R3is the side chain present on the C&agr; of an &agr;-amino acid; R4 is biphenylyl, benzyl, hydroxy-benzyl, &agr;- or &bgr;-naphthyl-methyl, 5,6,7,8-tetrahydro-&bgr;-naphthyl-methyl or indolyl-methyl, each being optionally substituted on the ring by CF3, halogen, OH, C1-4alkoxy, amino, mono- or di-C1-4alkyl substituted amino, phenyl, benzyl or C1-4alkyl optionally substituted by amino; and X is —CN, —NR5R6 or —O—R8 wherein R5 is H, C1-6alkyl, aryl or aryl-C1-4alkyl; R6 is H or C1-6alkyl;
    Type: Grant
    Filed: October 11, 2000
    Date of Patent: June 4, 2002
    Assignee: Novartis AG
    Inventors: Rainer Albert, Josef G. Meingassner, Sompong Wattanasin, Gabriele Weitz-Schmidt, Karl Welzenbach, Ulrich Hommel, Claus Ehrhardt, Didier Roche, Joerg Kallen
  • Patent number: 5366971
    Abstract: New use of 11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing themThe compounds of formula I, ##STR1## have been found to have excellent topical activity. They are thus indicated for use in the topical treatment of inflammatory and hyperpoliferative skin diseases and of cutaneous manifestations of immunologically-induced illnesses, such as psoriasis.
    Type: Grant
    Filed: November 30, 1992
    Date of Patent: November 22, 1994
    Assignee: Sandoz Ltd.
    Inventors: Maximilian Grassberger, Josef G. Meingassner, Anton Stutz, Peter Stutz
  • Patent number: 4148890
    Abstract: The invention provides a synergistic composition of a polyether antibiotic and a pleuromutilin derivative, which has an enhanced effect against coccidiosis in poultry. The composition may be prepared in the form of a premix concentrate and incorporated into commercial complete poultry feed. A method of treatment or prophylaxis of coccidiosis in poultry by co-administration of the components is also claimed.
    Type: Grant
    Filed: December 20, 1977
    Date of Patent: April 10, 1979
    Assignee: Sandoz Ltd.
    Inventors: Rudolf Czok, Josef G. Meingassner, Hubert Mieth, Eberhard Schutze